NEW YORK, Feb.21 (GenomeWeb News) - The Global Alliance for TB Drug Development and BG Medicine announced today a collaborative deal to identify biomarkers for tuberculosis drug development.
The collaboration will last six months, the partners said.
Under the deal, BG Medicine will use its proteomic and metabolomic analytical platforms to analyze samples provided by Colorado State University. TB Alliance will fund the project, with help from a grant from the Netherlands Ministry of Foreign Affairs.
Financial details were not provided.
TB Alliance is a non-profit, public-private partnership supported by the Bill and Melinda Gates Foundation and the Rockefeller Foundation.